Cosmo unveils strategic roadmap combining AI innovation with €480M revenue target. New vision integrates digital health, specialty pharma, and CDMO capabilities. Get full details.
Cosmo Reveals Ambitious €480M AI Healthcare Vision: 40% EBITDA Margin Target Signals Major Transformation
